반응형 HALOStockAnalysis1 Halozyme (HALO) Stock: $143M of Equity and $1.3B of Notes Halozyme Therapeutics (NASDAQ: HALO) earned an operating margin of 59.8% in the second quarter of 2026. Revenue was $481.0 million, operating income was $287.7 million, and royalties alone brought in $307.7 million, or 64.0% of the total.Stockholders' equity at the end of that quarter was $143.5 million. The shares trade at $112.45 for a market value of $12.76 billion, which puts the book value .. 2026. 9. 21. Previous 1 Next 반응형
